Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Verve Therapeutics, Inc.
IPO Date: July 17, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $427.44M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.81 | 3.94%
Avg Daily Range (30 D): $0.23 | 4.71%
Avg Daily Range (90 D): $0.26 | 4.72%
Institutional Daily Volume
Avg Daily Volume: .98M
Avg Daily Volume (30 D): 2.7M
Avg Daily Volume (90 D): 2.46M
Trade Size
Avg Trade Size (Sh.): 81
Avg Trade Size (Sh.) (30 D): 114
Avg Trade Size (Sh.) (90 D): 118
Institutional Trades
Total Inst.Trades: 1,407
Avg Inst. Trade: $2.02M
Avg Inst. Trade (30 D): $1.13M
Avg Inst. Trade (90 D): $1.1M
Avg Inst. Trade Volume: .13M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.41M
Avg Closing Trade (30 D): $1.11M
Avg Closing Trade (90 D): $1.07M
Avg Closing Volume: 160.31K
   
News
May 28, 2025 @ 11:00 AM
Verve Therapeutics to Participate in Upcoming Inve...
Source: N/A
May 19, 2025 @ 2:56 PM
Bio/Pharmaceutical Outsourcing Report, March 2025 ...
Source: Researchandmarkets.Com
Apr 18, 2025 @ 10:36 PM
Why Verve Therapeutics Zoomed 40% Higher This Week...
Source: Eric Volkman
Apr 15, 2025 @ 4:43 PM
Why Verve Therapeutics Is Skyrocketing Today
Source: Keith Noonan
Apr 11, 2025 @ 11:00 AM
Verve Therapeutics Receives U.S. FDA Fast Track De...
Source: N/A
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-2.11 $-.35 $-.58
Diluted EPS $-2.11 $-.35 $-.58
Revenue $ 59.61M $ 32.98M $ 13.08M
Gross Profit $ $ $
Net Income / Loss $ -181.01M $ -31.03M $ -50.04M
Operating Income / Loss $ -208.45M $ -36.64M $ -56.07M
Cost of Revenue $ $ $
Net Cash Flow $ -47.65M $ -76.01M $ 13.85M
PE Ratio